Implementation of Recommendations on the Use of Corticosteroids in Severe COVID-19.
Saved in:
| Title: | Implementation of Recommendations on the Use of Corticosteroids in Severe COVID-19. |
|---|---|
| Authors: | Camirand-Lemyre F; Université de Sherbrooke, Sherbrooke, Quebec, Canada., Merson L; ISARIC, Pandemic Sciences Institute, University of Oxford, Oxford, United Kingdom., Tirupakuzhi Vijayaraghavan BK; Department of Critical Care Medicine, Apollo Main Hospital, Chennai, India.; The George Institute for Global Health, New Delhi, India., Burrell AJC; Department of Epidemiology and Preventive Medicine, Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), Monash University, Melbourne, Victoria, Australia.; Alfred Hospital, Melbourne, Victoria, Australia., Citarella BW; ISARIC, Pandemic Sciences Institute, University of Oxford, Oxford, United Kingdom., Domingue MP; Université de Sherbrooke, Sherbrooke, Quebec, Canada., Lévesque S; Université de Sherbrooke, Sherbrooke, Quebec, Canada., Usuf E; Medical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, Fajara, The Gambia., Wils EJ; Franciscus Gasthuis & Vlietland, Rotterdam, the Netherlands.; Erasmus MC-University Medical Center, Rotterdam, the Netherlands., Ohshimo S; Department of Emergency and Critical Care Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan., Martin-Loeches I; Department of Intensive Care Medicine, Multidisciplinary Intensive Care Research Organization (MICRO), St James's Hospital Dublin, Leinster, Ireland., Sandulescu O; Department of Infectious Diseases I, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.; National Institute for Infectious Diseases Prof Dr Matei Balș, Bucharest, Romania., Laake JH; Department of Anaesthesiology and Intensive Care Medicine, Division of Critical Care and Emergencies, Rikshospitalet Medical Centre, Oslo University Hospital, Oslo, Norway., Lamontagne F; Université de Sherbrooke, Sherbrooke, Quebec, Canada. |
| Corporate Authors: | ISARIC Clinical Characterisation Group |
| Source: | JAMA network open [JAMA Netw Open] 2023 Dec 01; Vol. 6 (12), pp. e2346502. Date of Electronic Publication: 2023 Dec 01. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2574-3805 |
|---|---|
| DOI: | 10.1001/jamanetworkopen.2023.46502 |
